| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |